Quadrature Capital’s Novo Nordisk NVO Stock Holding History

Quadrature Capital’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25M	Sell	522,349 -505,399	-49%	-$21.7M	0.21%	97
2026 Q1	$37.8M	Sell	1,027,748 -149,185	-13%	-$7.07M	0.45%	51
2025 Q4	$59.9M	Buy	+1,176,933	New	+$60.2M	0.61%	47
2017 Q2	–	Sell	-64,394	Closed	-$1.1M	–	718
2017 Q1	$1.1M	Sell	64,394 -31,632	-33%	-$551K	0.08%	276
2016 Q4	$1.72M	Sell	96,026 -240,878	-71%	-$4.37M	0.11%	202
2016 Q3	$7M	Buy	+336,904	New	+$8.35M	0.61%	39
2016 Q2	–	Sell	-87,786	Closed	-$2.38M	–	614
2016 Q1	$2.38M	Buy	+87,786	New	+$2.35M	0.33%	85
2015 Q2	–	Sell	-72,800	Closed	-$1.94M	–	191
2015 Q1	$1.94M	Buy	+72,800	New	+$1.68M	2.83%	5

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Quadrature Capital's NVO Position: Q2 2026 in Review

Quadrature Capital reduced its Novo Nordisk (NVO) stake by 49% in Q2 2026, selling an estimated $21.7M and leaving 522,349 shares worth $25M. The position accounts for 0.21% of the portfolio, ranked #97.

Quadrature Capital first reported a position in NVO in Q1 2015 and has held it in 8 quarters since. The position peaked at $59.9M in Q4 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Quadrature Capital held 522,349 shares of Novo Nordisk worth $25M as of Q2 2026.
Quadrature Capital sold 505,399 Novo Nordisk shares in Q2 2026, an estimated $21.7M.
Novo Nordisk made up 0.21% of Quadrature Capital's portfolio in Q2 2026, its #97 holding.
Quadrature Capital first reported a position in Novo Nordisk in Q1 2015 and has held it in 8 quarters since.
Quadrature Capital's Novo Nordisk position peaked at $59.9M in Q4 2025.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.